TNFAIP8 Antikörper
Kurzübersicht für TNFAIP8 Antikörper (ABIN7469106)
Target
Alle TNFAIP8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Full length human TNFAIP8 Recombinant protein.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:1000-1:10000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Kommentare
-
Positive Control: A431
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 10 % Glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- TNFAIP8 (Tumor Necrosis Factor, alpha-Induced Protein 8 (TNFAIP8))
-
Andere Bezeichnung
- TNF alpha induced protein 8
-
Hintergrund
-
Synonyms: TNF alpha induced protein 8 , GG2-1 , MDC-3.13 , NDED , SCC-S2 , SCCS2
Background: Acts as a negative mediator of apoptosis and may play a role in tumor progression. Suppresses the TNF-mediated apoptosis by inhibiting caspase-8 activity but not the processing of procaspase-8, subsequently resulting in inhibition of BID cleavage and caspase-3 activation.
-
Molekulargewicht
- 23 kDa
-
Gen-ID
- 25816
-
UniProt
- O95379
Target
-